Naqvi Atta Abbas, Hassali Mohamed Azmi, Aftab Mohammad Tariq
Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Penang, Malaysia.
Department ofPharmacology and Toxicology, College of Medicine, Imam Abdul Rahman Bin Faisal University, Dammam, Saudi Arabia.
J Pak Med Assoc. 2019 Mar;69(3):389-398.
The study aimed to evaluate literature on rheumatoid arthritis disease in Pakistani patients, to have an understanding about its epidemiology, clinical aspects and socio-economic determinants.
The review study was conducted from December 2017, to May 2018. An online search was conducted in international and local health databases using appropriate search keywords as well as scanning reference lists of related articles. Literature published after year 2000 that reported epidemiological, demographic, clinical and socioeconomic data of Pakistani rheumatoid arthritis patients was included. Meta-analysis was performed where possible. This systematic review was registered on the international prospective register of systematic reviews PROSPERO (CRD42018090582).
Of the 334 research articles found, 29 (8.7%) were selected. Patients were mostly females, but no study explored impact of disease on household and family role functioning of rheumatoid arthritis-affected women in Pakistan. Most patients were uneducated (55%) and unemployed; had low disease knowledge (N = 149, 74.5%) and poor adherence to disease-modifying anti-rheumatic drugs (N = 23, 23%). Point prevalence of rheumatoid arthritis reported from Karachi was high at 26.9%. Moderate disease activity, i.e., 4.5}0.7 and mild functional disability (N = 66, 51.6%) were seen in RA patients. Almost half (N = 799, 46.9%) had comorbidities. Almost a fifth proportion of RA patients had dyslipidaemia as a comorbidity (N = 134, 16.77%) and higher cardiovascular risk score as modifiable risk factor. Undiagnosed depression (N = 134, 58.3%) and low bone mineral density (N = 93, 40.6%) were reported in RA patients. Direct monthly treatment cost of disease was significantly high considering patients' socio-economic status, i.e., USD 16.47 - 100.68. Most commonly used drug was methotrexate.
There is a paucity of data on Pakistani rheumatoid arthritis patients' demographic and socio-economic parameters, especially the gender element.
本研究旨在评估关于巴基斯坦类风湿关节炎患者的文献,以了解其流行病学、临床特征及社会经济决定因素。
本综述研究于2017年12月至2018年5月进行。通过在国际和本地健康数据库中使用适当的搜索关键词进行在线搜索,并浏览相关文章的参考文献列表。纳入2000年后发表的报告巴基斯坦类风湿关节炎患者流行病学、人口统计学、临床和社会经济数据的文献。尽可能进行荟萃分析。本系统综述已在国际前瞻性系统评价注册库PROSPERO(CRD42018090582)上注册。
在检索到的334篇研究文章中,29篇(8.7%)被选中。患者大多为女性,但没有研究探讨疾病对巴基斯坦类风湿关节炎女性患者家庭及家庭角色功能的影响。大多数患者未受过教育(55%)且失业;疾病知识水平低(N = 149,74.5%),对改善病情抗风湿药物的依从性差(N = 23,23%)。据报道,卡拉奇类风湿关节炎的点患病率较高,为26.9%。类风湿关节炎患者出现中度疾病活动,即4.5±0.7,以及轻度功能残疾(N = 66,51.6%)。近一半(N = 799,46.9%)患者有合并症。近五分之一的类风湿关节炎患者合并血脂异常(N = 134,16.77%),且心血管风险评分较高,这是一个可改变的风险因素。类风湿关节炎患者中报告有未确诊的抑郁症(N = 134,58.3%)和低骨密度(N = 93,40.6%)。考虑到患者的社会经济状况,疾病的直接月治疗费用显著较高,即16.47 - 100.68美元。最常用的药物是甲氨蝶呤。
关于巴基斯坦类风湿关节炎患者人口统计学和社会经济参数的数据匮乏,尤其是性别因素方面。